These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16787331)

  • 1. ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
    Eguchi M; Nguyen C; Lee SC; Kahn M
    Med Chem; 2005 Sep; 1(5):467-72. PubMed ID: 16787331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating Wnt signaling: a chemogenomic safari.
    McMillan M; Kahn M
    Drug Discov Today; 2005 Nov; 10(21):1467-74. PubMed ID: 16243267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
    Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
    Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.
    Teo JL; Ma H; Nguyen C; Lam C; Kahn M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12171-6. PubMed ID: 16093313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
    Emami KH; Nguyen C; Ma H; Kim DH; Jeong KW; Eguchi M; Moon RT; Teo JL; Kim HY; Moon SH; Ha JR; Kahn M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12682-7. PubMed ID: 15314234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.
    Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redirecting TGF-
    Qiao X; Rao P; Zhang Y; Liu L; Pang M; Wang H; Hu M; Tian X; Zhang J; Zhao Y; Wang XM; Wang C; Yu H; Guo F; Cao Q; Wang Y; Wang YM; Zhang GY; Lee VW; Alexander SI; Zheng G; Harris DCH
    J Am Soc Nephrol; 2018 Feb; 29(2):557-570. PubMed ID: 29180394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells.
    Kim YM; Ma H; Oehler VG; Gang EJ; Nguyen C; Masiello D; Liu H; Zhao Y; Radich J; Kahn M
    Curr Cancer Drug Targets; 2011 Feb; 11(2):213-25. PubMed ID: 21158719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
    Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
    World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
    Chen Z; Venkatesan AM; Dehnhardt CM; Dos Santos O; Delos Santos E; Ayral-Kaloustian S; Chen L; Geng Y; Arndt KT; Lucas J; Chaudhary I; Mansour TS
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4980-3. PubMed ID: 19640711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.
    Delgado ER; Yang J; So J; Leimgruber S; Kahn M; Ishitani T; Shin D; Mustata Wilson G; Monga SP
    Am J Pathol; 2014 Jul; 184(7):2111-22. PubMed ID: 24819961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription.
    Weiske J; Huber O
    J Cell Sci; 2005 Jul; 118(Pt 14):3117-29. PubMed ID: 16014379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
    Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
    Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling.
    Idogawa M; Masutani M; Shitashige M; Honda K; Tokino T; Shinomura Y; Imai K; Hirohashi S; Yamada T
    Cancer Res; 2007 Feb; 67(3):911-8. PubMed ID: 17283121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
    Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
    Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
    Ma H; Nguyen C; Lee KS; Kahn M
    Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assaying beta-catenin/TCF transcription with beta-catenin/TCF transcription-based reporter constructs.
    Biechele TL; Moon RT
    Methods Mol Biol; 2008; 468():99-110. PubMed ID: 19099249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
    Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
    Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
    Wang Z; Zhou L; Xiong Y; Yu S; Li H; Fan J; Li F; Su Z; Song J; Sun Q; Liu SS; Xia Y; Zhao L; Li S; Guo F; Huang P; Carson DA; Lu D
    Br J Pharmacol; 2019 Sep; 176(17):3390-3406. PubMed ID: 31236922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.